Acessibilidade / Reportar erro

Implications of ischemic penumbra for the diagnosis of brain death

Abstract

The data reviewed here suggest the possibility that a global reduction of blood supply to the whole brain or solely to the infratentorial structures down to the range of ischemic penumbra for several hours or a few days may lead to misdiagnosis of irreversible brain or brain stem damage in a subset of deeply comatose patients with cephalic areflexia. The following proposals are advanced: 1) the lack of any set of clinically detectable brain functions does not provide a safe diagnosis of brain or brain stem death; 2) apnea testing may induce irreversible brain damage and should be abandoned; 3) moderate hypothermia, antipyresis, prevention of arterial hypotension, and occasionally intra-arterial thrombolysis may contribute to good recovery of a possibly large subset of cases of brain injury currently regarded as irreversible; 4) confirmatory tests for brain death should not replace or delay the administration of potentially effective therapeutic measures; 5) in order to validate confirmatory tests, further research is needed to relate their results to specific levels of blood supply to the brain. The current criteria for the diagnosis of brain death should be revised.

ischemic penumbra; cerebral ischemia; intracranial pressure; traumatic brain injury; brain death; hypothermia; thrombolysis; apnea test


Braz J Med Biol Res, December 1999, Volume 32(12) 1479-1487

Implications of ischemic penumbra for the diagnosis of brain death

C.G. Coimbra

Laboratório de Neurologia Experimental, Departamento de Neurologia e Neurocirurgia, Universidade Federal de São Paulo, São Paulo, SP, Brasil

Text

References

Correspondence and Footnotes Correspondence and Footnotes Correspondence and Footnotes

The data reviewed here suggest the possibility that a global reduction of blood supply to the whole brain or solely to the infratentorial structures down to the range of ischemic penumbra for several hours or a few days may lead to misdiagnosis of irreversible brain or brain stem damage in a subset of deeply comatose patients with cephalic areflexia. The following proposals are advanced: 1) the lack of any set of clinically detectable brain functions does not provide a safe diagnosis of brain or brain stem death; 2) apnea testing may induce irreversible brain damage and should be abandoned; 3) moderate hypothermia, antipyresis, prevention of arterial hypotension, and occasionally intra-arterial thrombolysis may contribute to good recovery of a possibly large subset of cases of brain injury currently regarded as irreversible; 4) confirmatory tests for brain death should not replace or delay the administration of potentially effective therapeutic measures; 5) in order to validate confirmatory tests, further research is needed to relate their results to specific levels of blood supply to the brain. The current criteria for the diagnosis of brain death should be revised.

Abstract

Key words: ischemic penumbra, cerebral ischemia, intracranial pressure, traumatic brain injury, brain death, hypothermia, thrombolysis, apnea test

Criticism

Irreversible damage to the brain stem or whole brain is assumed when consciousness and cephalic reflexes remain absent usually for six hours in a patient with known intracranial pathology, provided that reversible conditions such as drug intoxication, hypothermia, and metabolic or endocrine disturbance are reliably excluded (1,2). A 10-min apnea testing is advised to evaluate the respiratory reflex (2). Among several alternatives, a flat electroencephalogram (EEG) or an angiogram showing no images of intracranial vessels may ultimately confirm death for procurement of transplantable organs, but the reliability of neurological examination followed by apnea testing has been mostly considered, up to the point of regarding brain death as a clinical diagnosis (2).

In most cases progressing to brain death, the damage to the brain is of an ischemic nature. Hemorrhage, edema, and/or swelling progressively increase intracranial pressure (ICP), thereby reducing the perfusion pressure and brain blood flow (BBF). Irreversible damage to the nervous tissue results from maximally increased ICP which reduces BBF beyond recovery. However, that may not be the actual pathophysiological condition of a possibly large number of cases fulfilling the current diagnostic criteria for brain death.

Accumulated knowledge on the pathophysiology of ischemic damage to diverse body tissues has invalidated the assumption that a sustained absence of the specialized cellular functions is invariably irreversible or reflects cell necrosis. For instance, a region of the myocardium rendered akinetic as a consequence of a partial reduction in blood supply may actually resume contraction upon restoration of normal circulation (the phenomenon of the hibernating myocardium) (3). Similarly, under incomplete ischemic conditions (BBF between 10.0 and 35.0 ml 100 g-1 min-1; 4), suppressed neurological functions remain recoverable by recirculation for up to 48 h, provided that the oxygen extraction fraction continues to be elevated (5). The phenomenon is known as ischemic penumbra and was originally described by Astrup and colleagues (6). Disruption of ionic homeostasis occurs only at BBF levels lower than 10.0 ml 100 g-1 min-1, and launches the cascade of detrimental biochemical reactions that determines irreversible damage to the brain tissue within approximately one hour under such severe ischemic conditions (4). Rather than an exclusive attribute of the outer zone of focal ischemia, the phenomenon of ischemic penumbra is clearly a consistent response of general brain structures to partially reduced circulatory levels.

In contrast to the postulates related to the diagnosis of brain death and brain stem death, it is conceivable that partial occlusions of the vertebro-basilar artery, or progressive hypertension affecting either the whole intracranial space or solely the infratentorial compartment may keep the blood supply to the whole brain or to the brain stem within the range of ischemic penumbra for many hours. This pathophysiological concept advanced here is referred to as global ischemic penumbra or GIP. Its importance for understanding the relationship between the BBF levels and clinical findings in patients with progressively increased ICP is illustrated by the 3 hypothetical case examples presented in Figures 1 to 3.

At least two unique features may enhance the survival of brain tissue under GIP as compared with the penumbra zone of focal ischemia. Firstly, the absence of a source of neurotoxins contiguous to the whole tissue under reduced perfusion in GIP contrasts with the situation of focal ischemia. The infarcted core of the latter continuously releases diverse neurotoxins (including excitotoxins, nitric oxide and other inflammatory mediators) into the vicinity, and triggers repeated episodes of spreading depression that exhaust the already marginal energy supplies of the adjacent penumbra zone, leading to transformation of hitherto non-lethal injury into an irreversible one (5). Secondly, the decreased perfusion pressure that causes GIP may conversely attenuate the accumulation of vasogenic edema and taper off further increases in ICP, thereby sustaining the BBF within the upper range of ischemic penumbra for many hours or a few days.

As illustrated in Figure 1, the secretory functions of the hypothalamus may be sustained by BBF levels lower than those required for synapse-dependent brain functions such as those evaluated for the diagnosis of brain death. The existence of different thresholds of BBF for the maintenance of different specialized activities of the brain is supported by studies demonstrating regional glucose consumption. Under normal conditions the metabolic rate of the hypothalamus is about one-third of that observed in cerebral cortex (7).

Figure 1
- Evolution of brain blood flow (BBF) in three hypothetical cases of increased intracranial pressure (ICP) with absent supraspinal synaptic activity (coma and absent cephalic reflexes) for at least 48 h prior to cardiac arrest at 60 h-survival. While in case 1 brain damage becomes irreversible within 6 h from the onset of the "brain death" syndrome, in case 2 irreversibility is only achieved within 24 h, and in case 3 the brain tissue is still recoverable by the time of cardiac arrest which may result from metabolic disorders related to hypothalamic failure. If case 1 was representative of all (or at least most) cases of increased ICP at risk of brain death, full maturation of pathological features would develop during the next 48 h of continuous heart beating, and nearly 100% of autopsies (if not all of them) should demonstrate the respirator brain. In contrast, since respirator brain is only seen in 40% of these cases (21), global ischemic penumbra of variable duration is to be alternatively considered. CCtx & BrSt = BBF threshold below which cerebral cortex and brain stem functions become inactive (35 ml 100 g-1 min-1); DAMAGE = BBF threshold below which cells depolarize (10-15 ml 100 g-1 min-1). HyTh = BBF threshold below which hypothalamic secretory functions become inactive (CCtx & BrSt > HyTh > DAMAGE).

The hypothalamus is supplied with blood from the circle of Willis, and is expected to undergo the same level of circulatory shortage as any other intradural structure as a consequence of increased ICP. As the hypothalamic nuclei provide both the releasing hormones for the anterior hypophysis and the hormones to be liberated from the posterior hypophysis, preserved hypothalamic-hypophyseal function in some patients presumed to be brain dead cannot be explained by a hypothetical collateral blood flow to the anterior hypophysis through the inferior hypophyseal arteries arising extradurally from the internal carotid arteries. A reduced BBF down to 10.0 ml 100 g-1 min-1 or less would also disrupt the ionic homeostasis at all hypothalamic nuclei and result in failure of both anterior and posterior hypophyseal lobes.

Sustained hypophyseal function is therefore indirect evidence for active function, circulation and structural integrity of hypothalamic nuclei. Gramm and co-workers (8) followed 32 potential organ donors over a period of up to 80 h after the diagnosis of brain death established according to current criteria, determining the serum and plasma concentrations of hypothalamic-pituitary hormones, thyroid hormones, and cortisol. While 78% of the subjects eventually developed diabetes insipidus during the period of observation, no hormone concentration (except for arginine vasopressin) was found to be subnormal. In addition, none of the circulating hormones of the anterior hypophysis declined progressively according to their plasma half-lives from the onset of the "brain-death syndrome". These results are in agreement with earlier and less extensive studies (9,10).

Direct evidence of sustained hypothalamic secretory activity was provided by Arita and co-workers (11) who measured the serum concentrations of 3 different releasing hormones (growth hormone-releasing hormone - GH-RH, adrenocorticotrophic hormone-releasing hormone - ACTH-RH, luteinizing hormone-releasing hormone - LH-RH) in 24 cases within 24 h after the diagnosis of brain death. Serum concentrations were above the sensitivity of the radio-immunoassay (higher than 5 pg/ml for GH-RH, 2 pg/ml for ACTH-RH, 0.2 pg/ml for LH-RH) in 13 out of 23 cases for GH-RH, in 12 out of 19 cases for ACTH-RH, and in 21 out of 22 cases for LH-RH. In general, one or more hypothalamic hormones were detectable in every case. Sustained thermoregulation, paradoxically considered a prerequisite for the diagnosis of brain death (2), is clear evidence for preserved hypothalamic function and rather suggests GIP in patients with increased ICP and suppressed cephalic reflexes. Therefore, although eventually depressed (as suggested by signs of diabetes insipidus), the blood supply to the hypothalamus seems to be high enough to sustain most of its secretory functions in most patients for the first 2-3 days after the current criteria for the diagnosis of brain death are fulfilled.

Sustained hypothalamic circulation (implying circulation above 10.0 ml 100 g-1 min-1), when concomitant with deep coma and cephalic areflexia, also suggests that the neural structures with higher metabolic demands (as those functionally evaluated for the diagnosis of brain death) may be under GIP. That situation is illustrated in Figure 1 with hypothetical case examples No. 2 (from 11- to 33-h survival) and 3 (from 14- to 48-h survival).

On the other hand, the concept of GIP contradicts the assumption that hypercarbia induced by apnea testing would help to differentiate recoverable from irreversible cases of brain stem injury. Rather, hypercarbia may further impair the blood supply to the brain stem in these patients. Although vascular responses to changes in CO2 are diminished, for instance, in victims of severe head trauma, some reactivity persists even in deeply comatose patients. As intracranial compliance is remarkably reduced following severe head trauma, even a minor hypercarbia-induced aggravation of brain swelling may largely worsen the intracranial hypertension and the resulting global ischemic insult (12).

Furthermore, in about 40% of cases, apnea testing induces severe hypotension (13), which is the most important secondary insult related to poor outcome (death or persistent vegetative state) in human victims of severe head trauma (14). Preservation of brain blood flow in these patients requires significantly higher levels of perfusion pressure than in other individuals (12). Accordingly, transient arterial hypotension leads to irreversible collapse of intracranial circulation in cats subjected to severe head trauma, so that even supranormal levels of perfusion pressure cannot restore the brain blood flow in these animals (15). The sudden association of hypercarbia-induced increase in ICP with severe hypotension (presumably related to the detrimental effects of acidemia on the myocardium) possibly enables the establishment of tension forces between the intraluminal surfaces of brain vessels, and thereby causes irreversible collapse of intracranial circulation. Therefore, apnea testing may induce rather than diagnose irreversible damage to brain tissue, and the results of all confirmatory tests carried out thereafter may reflect the deleterious effects of induced apnea with or without hypoxia.

Direct measurements of BBF following the diagnosis of brain death support the detrimental effects of apnea testing. Due to such a sudden and permanent efflux of blood volume from intracranial space (vascular collapse) determined by apnea testing, normal levels of intracranial and perfusion pressures may be subsequently found in paradoxical association with absent or extremely reduced intracranial blood flow (less than 10.0 ml 100 g-1 min-1). Accordingly, Obrist and colleagues (16) found this combination of features in all of 9 patients fulfilling the current diagnostic criteria for brain death. Their results were in complete disagreement with those of the study by Baslev-Jørgensen and colleagues (17) carried out several years earlier, when the apnea test was not part of the routine for the diagnosis of brain or brain stem death. During progression to brain death - solely defined as "loss of cranial nerve reflexes and flat EEG" in deeply comatose patients - these authors found that "ICP increased to and remained at or above the level of mean arterial pressure" in all of 10 patients up to spontaneous cardiac arrest.

The consistent low levels of BBF found by Obrist and colleagues (16) are also in disagreement with earlier data obtained by other investigators who (like Baslev-Jørgensen and colleagues, 17) did not induce the apnea test. In three studies (18-20) comprising altogether 12 cases of deep coma and wide pupils, dependent on mechanical ventilation, 6 patients (50%) presented circulatory values ranging from 11.0 to 32.0 ml 100 g-1 min-1 - therefore characteristic of ischemic penumbra. The electroencephalogram was not flat only in those cases whose levels of BBF were in the upper range of ischemic penumbra (³25.0 ml 100 g-1 min-1; 20), suggesting that the values encountered did reflect actual levels of BBF. The possible detrimental effects of the apnea test on a subset of potentially recoverable hypothetical case examples (No. 2 and 3) are illustrated in Figure 2.

Figure 2
- Evolution of brain blood flow (BBF) in three hypothetical cases of intracranial hypertension: influence of hypotension induced by apnea testing at 24-h survival. Whilst BBF is unaffected in case 1, apnea testing hastens and sets the clinical outcome to irreversible brain damage in cases 2 and 3 by inducing collapse of intracranial vessels. For abbreviations see legend to Figure 1.

This percent value (50% of patients in deep coma and cephalic areflexia presenting BBF levels within the range of ischemic penumbra) is in close agreement with histopathological data obtained from the largest collaborative work so far carried out (see Figure 1) - The NINCDS Collaborative Study of Brain Death -, which included 226 autopsies (21). As in most early studies that followed the emergence of brain death in medical practice, apnea testing was avoided, and the "lack of any observed effort of the patient to override the respirator or by a ventilatory effort or movement other than that induced by the respirator" was chosen to characterize the loss of respiratory reflex (22). The signs of necrosis that characterize the so-called "respirator brain" (21) were found in only about 40% of cases of deep coma and absent brain stem reflexes for at least 6 h (21). Forty-eight hours of cephalic areflexia did not significantly change that percent value (21). In contrast with the quite consistent structural damage following a 4-min apnea test (23), the brain stem was morphologically intact in 15% of all cases (21).

Yet, moderate hypothermia (33oC) sustained for a few hours enables resumption of normal daily life in 70 and 50% of the patients following severe head trauma (24,25) and normothermic cardiac arrest lasting for 30-47 min (24)respectively, including individuals with nonreactive and wide pupils and a Glasgow coma scale of 3 on admission or following successful cardiac reanimation. Those surprisingly good results were obtained despite the fact that the neurological conditions of the head trauma victims probably further deteriorated from admission up to an average survival of 16 h, when a 24-h treatment with moderate hypothermia was initiated (25).

The mechanisms that account for recovery from such a pre-mortal state may include a) avoidance of detrimental effects related to apnea testing (26), b) normalization of ICP (recirculation from GIP - see Figure 3) during cooling to 33oC (27), c) regression of brain edema (27), d) inhibition of the detrimental cascade of neurochemical events triggered by a transient ischemic insult (28), and e) prevention of intracranial thermal pooling that increases brain temperature to levels capable of damaging vascular and neuronal proteins (29).

Figure 3
- Evolution of brain blood flow in three hypothetical cases of increased intracranial pressure (ICP): influence of moderate hypothermia (33oC) induced at 24-h survival. Simultaneous normalization of intracranial pressure observed during cooling to 33oC (27) leads to recirculation of cases 2 and 3 whilst case 1 is unaffected. Remarkable absorption of brain edema during the next few hours of hypothermic treatment should prevent recurrence of ICP (27). For abbreviations see legend to Figure 1.

Brain temperature may reach more than 2oC above rectal temperature, and antipyresis effectively reduces this difference (30). In addition to reducing acute neuronal damage (31),postischemic administration of an antipyretic drug prevented the development of chronic neurodegeneration when associated with the hypothermic treatment in rats (32). Accordingly, Jones and co-workers (33) found hyperthermia to be one of the most important determinants of poor outcome following head trauma. Prevention of arterial hypotension also impedes intracranial thermal pooling (29), and may act synergistically with antipyresis to protect the injured brain tissue.

Cases of basilar artery occlusion presenting apneic coma seem to evolve invariably to death when recirculation is not induced (34). In contrast, intra-arterial thrombolysis has been reported to induce remarkable functional recovery from basilar artery occlusion in a case of apneic coma and cephalic areflexia for 4-6 h (35). A subset of these cases may therefore sustain ischemic penumbra of the brain stem for a few hours from the onset of symptoms, and respond to timely intra-arterial thrombolysis, provided that apnea is not allowed for the diagnosis of brain death.

Absence of clinically detectable cephalic reflexes may occur in association with other signs of preserved brain stem function. Cortical somatosensory-evoked potentials were abolished 46 h but not 2.5 and 22 h after the onset of brain stem death syndrome in a case of cerebellar hemorrhage (36). Similarly, the existence of spinal cord cardiovascular centers does not exclude the brain stem as the anatomical site responsible for maintenance of normal blood pressure, or for the hemodynamic responses to surgical incisions for removal of transplantable organs in patients currently diagnosed as brain or brain stem dead (37). Rather, the absence of a recordable period of profound hypotension that follows acute inactivation of vasomotor centers by ischemia due to rising intracranial pressure is not consistent with that diagnosis (37).

The diverse cephalic reflexes evaluated for the clinical diagnosis of brain death do not disappear simultaneously as the blood supply to the brain stem decreases (38), suggesting that some synaptic circuits expend higher amounts of energy than others. Similarly, both the neuronal control of hemodynamic conditions and the verification of somatosensory-evoked potentials may require lower levels of blood supply than the demonstration of cephalic reflexes upon neurological examination. Accordingly, even the evidence for one single and depressed sign of brain stem activity may imply levels of infratentorial blood flow above the threshold associated with disruption of ionic homeostasis of neuronal cells. Therefore, these signs may identify patients with a higher likelihood for recovery following resuscitative hypothermia (39).

As compared to tests for those synapse-dependent functions, which are expected to be cumulatively suppressed as BBF falls from around 35.0 ml 100 g-1 min-1, the validation of direct tests for intracranial circulatory arrest is even less clear, and may provide paradoxical results. Even after fulfillment of clinical diagnostic criteria, the vertebro-basilar artery remained visible on 2 consecutive daily angiograms in a case of infratentorial hemorrhage (40). Other cases of delayed or partial opacification of the intracranial arteries following the diagnosis of brain death have been reported (41-46). Conversely, angiography may fail to detect intracranial blood flow despite indirect evidence for continuous endocrine activity of hypothalamic nuclei (8,9). These data contradict the long-held assumption that the absence of angiographic images of brain arteries should be considered an indisputable evidence for intracranial circulatory arrest. Actually, for optimal visualization of vascular images, the contrast media must be infused intra-arterially at specific rates considering a normal range of intracranial blood flow (47). A reduced perfusion pressure may therefore decrease the brain blood flow and affect vascular opacification (48). Angiographic findings as well as the results of other less reliable confirmatory tests therefore are to be correlated with specific levels of intracranial blood flow.

The hypothesis of GIP is supported by both direct and indirect data, and is in agreement with previous criticisms against a) the definition of brain death by statute as "irreversibility of cessation of brain function" (49), and b) current misconceptions regarding diagnosis and prognosis of death (50). More effective therapeutic resources based on new pathophysiological concepts may improve the prognosis of patients in critical conditions. Likewise, the confirmation of the GIP hypothesis may indicate the value of hypothermia and other resources for the treatment of a subset of patients in a coma with cephalic areflexia nowadays conceivably misdiagnosed as neurologically unrecoverable.

Address for correspondence: C.G. Coimbra, Laboratório de Neurologia Experimental, Universidade Federal de São Paulo, Rua Botucatú, 862, Ed. Leal Prado, 04023-900 São Paulo, SP, Brasil. Fax: +55-11-539-3123/573-9304. E-mail: coimbracg.nexp@epm.br

Research supported by CNPq, FAPESP and PRONEX. Received July 26, 1999. Accepted September 29, 1999.

  • 1. Pallis C (1982). ABC of brain stem death. Diagnosis of brain stem death - I. British Medical Journal, 285: 1558-1560.
  • 2. Wijdicks EFM (1995). Determining brain death in adults. Neurology, 45: 1003-1011.
  • 3. Marwick TH (1998). The viable myocardium: epidemiology, detection, and clinical implications. Lancet, 351: 815-819.
  • 4. Fisher M (1997). Characterizing the target of acute stroke therapy. Stroke, 28: 866-872.
  • 5. Kalimo H, Kaste M & Haltia M (1997). Vascular diseases. In: Graham DI & Lantos PL (Editors), Greenfield's Neuropathology Arnold, London.
  • 6. Astrup J, Symon L & Siesjö BK (1981). Thresholds in cerebral ischemia: the ischemic penumbra. Stroke, 12: 723-725.
  • 7. Kennedy C, Sakurada O, Shinohara M, Jehle J & Sokoloff L (1978). Local cerebral glucose utilization in the normal conscious Macaque monkey. Annals of Neurology, 4: 393-401.
  • 8. Gramm H-J, Meinhold H, Bickel U, Zimmermann J, Hammerstein B, Keller F, Dennhardt R & Voigt K (1992). Acute endocrine failure after brain death? Transplantation, 54: 851-857.
  • 9. Schrader H, Krogness K, Aakvaag A, Sortland O & Purvis K (1980). Changes of pituitary hormones in brain death. Acta Neurochirurgica, 52: 239-248.
  • 10. Satzontseva IE, Kozlov IA, Moisuc YG, Ermolenko AE, Afonin VV & Ilnitskiy VV (1991). Hormonal response to brain death. Transplantation Proceedings, 23: 2467.
  • 11. Arita K, Uozumi T, Oki S, Kurisu K, Ohtani M & Mikami T (1993). The function of the hypothalamo-pituitary axis in brain dead patients. Acta Neurochirurgica, 123: 64-75.
  • 12. Miller JD (1982). Physiology of trauma. Clinical Neurosurgery, 29: 103-130.
  • 13. Jeret JS & Benjamin JL (1994). Risk of hypotension during apnea testing. Archives of Neurology, 51: 595-599.
  • 14. Chesnut RM (1997). Avoidance of hypotension: condition sine qua non of successful severe head-injury management. Journal of Trauma, 42: S4-S9.
  • 15. Lewelt W, Jenkins L & Miller JD (1980). Autoregulation of cerebral blood flow after experimental fluid percussion injury of the brain. Journal of Neurosurgery, 53: 430-511.
  • 16. Obrist WD, Jaggi JL, Langfitt TW & Zimmerman RA (1981). Cessation of CBF in brain death with normal perfusion pressure. Journal of Cerebral Blood Flow and Metabolism, 1 (Suppl 1): S524-S525.
  • 17. Baslev-Jřrgensen PB, Heilbrun MP, Boysen G, Rosenklint A & Jřrgensen EO (1972). Cerebral perfusion pressure correlated with regional cerebral blood flow, EEG and aortocervical arteriography in patients with severe brain disorders progressing to brain death. European Neurology, 8: 207-212.
  • 18. Hoyer S & Wawersik J (1968). Untersuchungen der Hirndurchblutung und des Hirnstoffwechsels beim Decerebrationssyndrom. Langenbecks Archiv für Chirurgie, 322: 602-605.
  • 19. Bes A, Arbus L, Lazorthes Y, Delpla M & Escande M (1969). Hemodynamic and metabolic studies of coma depassé. Research on biological criteria for cerebral death. International Cerebral Blood Flow Symposium, April 1969, Mainz, Germany.
  • 20. Shalit MN, Beller J, Feinsod M, Drapkin AJ & Cotev S (1970). The blood flow and oxygen consumption of the dying brain. Neurology, 20: 740-748.
  • 21. Walker AE, Diamond El & Mosely JI (1975). The neuropathological findings in irreversible coma. Journal of Neuropathology and Experimental Neurology, 34: 295-323.
  • 22. Allen N, Burkholder JD, Molinari GF & Comiscioni J (1980). Clinical criteria of brain death. In: The NINCDS Collaborative Study of Brain Death National Institutes of Health, Bethesda, MD, NIH publication 81-2286: 77-147.
  • 23. Mohandas A & Chou SN (1971). Brain death. A clinical and pathological study. Journal of Neurosurgery, 35: 211-218.
  • 24. Hayashi N (1996). Brain hypothermia therapy. Japanese Medical Journal, 3767: 21-27.
  • 25. Metz C, Holzschuh M, Bein T, Woertgen C, Frey A, Frey I, Taeger K & Brawanski A (1996). Moderate hypothermia in patients with severe head injury and extracerebral effects. Journal of Neurosurgery, 85: 533-541.
  • 26. Watanabe Y (1997). Once again on cardiac transplantation. Flaws in the logic of proponents. Japanese Heart Journal, 38: 617-624.
  • 27. Schwab S, Spranger M, Aschoff A, Steiner T & Hacke W (1997). Brain temperature monitoring and modulation in patients with severe MCA infarction. Neurology, 48: 762-767.
  • 28. Coimbra C & Wieloch T (1994). Moderate hypothermia mitigates neuronal damage in the rat brain when initiated several hours following transient cerebral ischemia. Acta Neuropathologica, 87: 325-331.
  • 29. Hayashi N, Hirayama A, Udegawa A, Daimon W & Ohata M (1994). Systemic management of cerebral edema based on a new concept in severe head injury patients. Acta Neurochirurgica, 60 (Suppl): 541-543.
  • 30. Mellergĺrd P (1994). Monitoring of rectal, epidural and intraventricular temperature in neurosurgical patients. Acta Neurochirurgica, 60 (Suppl): 485-487.
  • 31. Coimbra C, Boris-Möller F, Drake M & Wieloch T (1996). Diminished neuronal damage in the rat brain by late treatment with the antipyretic dipyrone or cooling following cerebral ischemia. Acta Neuropathologica, 92: 447-453.
  • 32. Coimbra C, Drake M, Boris-Möller F & Wieloch T (1996). Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug: evidence for chronic encephalopathic processes following ischemia. Stroke, 27: 1578-1585.
  • 33. Jones PA, Andrews PJ, Midgley S, Anderson SI, Piper IR, Tocher JL, Houstley AM, Corrie JA, Sattery J & Dearden NM (1994). Measuring the burden of secondary insults in head-injured patients during intensive care. Journal of Neurosurgical Anesthesiology, 6: 4-14.
  • 34. Wijdicks EFM & Scott JP (1996). Outcome in patients with acute basilar artery occlusion requiring mechanical ventilation. Stroke, 27: 1301-1303.
  • 35. Koberda JL, Clark WM, Lutsep H & Nesbit G (1997). Successful clinical recovery and reversal of mid-basilar occlusion in clinically brain dead patient with intra-arterial urokinase. Neurology, 48 (Suppl): A154 (Abstract).
  • 36. Wagner W, Ungersböck K & Perneczky A (1993). Preserved cortical somatosensory evoked potentials in apnoeic coma with loss of brain-stem reflexes: case report. Journal of Neurology, 240: 243-246.
  • 37. Evans DW & Hill DJ (1987). Brain death. Lancet, 2: 102.
  • 38. Jřrgensen PB (1973). Clinical deterioration prior to brain death related to progressive intracranial hypertension. Acta Neurochirurgica, 28: 29-40.
  • 39. Krieger DW (1998). Evoked potentials not just to confirm hopelessness in anoxic brain injury. Lancet, 352: 1796-1797.
  • 40. Kosteljanetz M, Řhrstrřm JK, Skjřdt S & Teglbjćrg PS (1988). Clinical brain death with preserved cerebral arterial circulation. Acta Neurologica Scandinavica, 78: 418-471.
  • 41. Riishede J & Ethelberg S (1953). Angiographic changes in sudden and severe herniation of the brain tissue through tentorial incisura. Report of 5 cases. Archives of Neurology and Psychiatry, 70: 399-409.
  • 42. Pibram HFW (1961). Angiographic appearances in acute intracranial hypertension. Neurology, 11: 10-21.
  • 43. Mitchell EC, de la Torre E, Alexander E & Davis CH (1962). The non-filling phenomenon during angiography in acute intracranial hypertension. Report of 5 cases and experimental study. Journal of Neurosurgery, 19: 766-774.
  • 44. Korein J, Braunstein P, George A, Witcher M, Kricheff I, Lieberman A & Pearson J (1977). Brain death. Angiographic correlation with radioisotopic bolus technique for evaluation of critical deficit of cerebral blood flow. Annals of Neurology, 2: 195-205.
  • 45. Kouji H, Kawahara N, Mii K & Takakura K (1989). Analysis of angiographic findings in patients with severe brain disorders progressing to brain death. No To Shinkei, 41: 727-735.
  • 46. Nau R, Prange HW, Klingelhöfer J, Kucowski B, Sander D, Tchorsch R & Rittmeyer K (1992). Results of four technical investigations in fifty clinically brain dead patients. Intensive Care Medicine, 18: 82-88.
  • 47. Osborn AG (1980). Introduction to Cerebral Angiography Harper & Row, Philadelphia.
  • 48. Brock M, Schürmann K & Hadjidimos A (1969). Cerebral blood flow and cerebral death. Preliminary report. Acta Neurochirurgica, 20: 195-209.
  • 49. Byrne PA, O'Reilly S & Quay PM (1979). Brain death - An opposing viewpoint. Journal of the American Medical Association, 242: 1985-1990.
  • 50. Shewmon DA (1987). The probability of inevitability: the inherent impossibility of validating criteria for brain death or 'irreversibility' through clinical studies. Statistics in Medicine, 6: 535-553.
  • Correspondence and Footnotes

  • Publication Dates

    • Publication in this collection
      26 Nov 1999
    • Date of issue
      Dec 1999

    History

    • Accepted
      29 Sept 1999
    • Received
      26 July 1999
    Associação Brasileira de Divulgação Científica Av. Bandeirantes, 3900, 14049-900 Ribeirão Preto SP Brazil, Tel. / Fax: +55 16 3315-9120 - Ribeirão Preto - SP - Brazil
    E-mail: bjournal@terra.com.br